Eight stock picks to play one of the healthiest corners of the market

The healthcare sector of the U.S. stock market as a whole is cheaply priced, which can make it attractive to investors concerned that the S&P 500 has gotten too expensive several years into a bull market.

Market Watch • Dec 11, 2025

Masimo (MASI) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 10, 2025

HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Masimo Corporation (NASDAQ: MASI) breached their fiduciary duties to shareholders.

PRNewsWire • Dec 5, 2025

Masimo Pitches 2028 Plan With 30% Operating Margins

Masimo Corp (NASDAQ: MASI) on Wednesday hosted its 2025 Investor Day. At the event, Masimo's management team provided an update on the company's long-term strategy.

Benzinga • Dec 4, 2025

Masimo Corporation (MASI) Analyst/Investor Day Transcript

Masimo Corporation (MASI) Analyst/Investor Day Transcript

Seeking Alpha • Dec 4, 2025

Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company's headquarters. At the event, Masimo's management team provided an update on the Company's long-term strategy, including the pathway for expanding Masimo's position as a global leader in patient monitoring, the Company's multi-year pipeline, and a clear roadmap to deliver durable revenue growth, margin expansion and increased cash flow. Masimo also provided a detailed look at each of its gro.

Business Wire • Dec 3, 2025

Here's Why Masimo (MASI) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Nov 24, 2025

Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Nov 24, 2025

Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case

IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring technology.

PRNewsWire • Nov 18, 2025

Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade

The mean of analysts' price targets for Masimo (MASI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Nov 18, 2025